Loading
The supportive-care tools with real evidence: exercise, heart protection, hair preservation, fitness assessment for older adults, and the questions to ask.
Supportive care and survivorship covers everything that keeps a patient well enough to receive treatment, and well afterwards.
Why here The front that gets the least attention and changes daily life the most.
Structured exercise during and after treatment, which the CHALLENGE trial showed improves survival in colon cancer.
Why here Structured exercise improved survival in a randomised trial.
The CHALLENGE trial showed a supervised exercise programme improves survival in colon cancer. Extend it to breast, prostate, and lung cancer with the same rigour.
Why here Why exercise should be prescribed like a drug.
Cardio-oncology builds heart risk assessment, monitoring and prevention into cancer care so patients can finish curative treatment without trading cancer for heart failure. It targets anthracycline and trastuzumab damage, checkpoint-inhibitor myocarditis and radiation heart disease using echocardiography, troponin tests and protective drugs; specialist clinics are concentrated in large centres.
Why here Protecting the heart from anthracyclines, HER2 drugs, and immunotherapy.
A tightly fitted cap chilled to a few degrees above freezing, worn before, during and after each chemotherapy infusion, narrows the blood vessels of the scalp so less drug reaches the hair roots. In a randomised trial about half of women on taxane-based chemotherapy kept most of their hair, compared with none who went without.
Why here Keeping hair through taxane chemotherapy.
Geriatric assessment is a structured check of an older patient's fitness, memory, and support that predicts treatment tolerance better than age.
Why here For older patients: fewer severe side effects without losing effect.
Immune-related adverse events (irAEs) are the autoimmune side effects of checkpoint inhibitors: colitis, thyroid problems, rash, hepatitis, pneumonitis.
Why here Immunotherapy side effects to recognise early.
Interstitial lung disease (ILD) is lung inflammation, a serious side effect of some ADCs (especially Enhertu) and immunotherapy.
Why here The lung side effect of some ADCs, and why prompt reporting matters.
An ultra-sensitive blood test after surgery that detects leftover cancer months before a scan would.
Why here Blood tests during follow-up and what they can and cannot yet tell you.
Nonprofit that helps advanced-cancer patients navigate precision-oncology options and trials, free of charge.
Why here Free navigation help when options run thin.